Abstract
Tissue Doppler Tei index is pointed to be more effective in the evaluation of global cardiac function than systolic and diastolic measurements alone in various heart diseases. This study was designed to assess the effect of cilnidipine on left ventricular function in hypertensive patients by using this index. A group of 40 hypertensives (mean age 55±8 years, range: 35–65) and 16 controls (mean age 52±9 years, range: 36–65) were included. Hypertensives were classified into non-left ventricular hypertrophy (NLVH) group (25 patients) and left ventricular hypertrophy (LVH) group (15 patients), and treated with cilnidipine for 2 months. Before and after treatment, the participants were examined by echocardiography. Tissue Doppler Tei index was calculated as diastolic time interval measured from end of late diastole to origin of early diastole (a′) minus systolic Sm duration (b′) divided by b′, that is Tei index=(a′–b′)/b′. Thirty-seven hypertensive patients finished the treatment. Tei index was significantly higher in NLVH and LVH groups than in control group, and in LVH group than in NLVH group (0.44±0.07 vs 0.28±0.06, P<0.001; 0.51±0.13 vs 0.28±0.06, P<0.001; 0.51±0.13 vs 0.44±0.07, P<0.05). After treatment, Tei index was significantly decreased (0.40±0.11 vs 0.46±0.10, P<0.0001); systolic blood pressure and diastolic blood pressure were also decreased significantly. In conclusion, Tei index is impaired in hypertensives before development of ventricular hypertrophy and impairment is more prominent in hypertrophy. Cilnidipine can improve left ventricular function. Tissue Doppler Tei index is gaining importance in evaluating LV function after drug intervention in hypertensive patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stamler J, Neaton JD, Wentworth DN . Blood pressure and risk of fatal coronary heart disease. Hypertension 1989; 13: I2–I12.
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacretaz E, Allemann Y . Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 14: 106–113.
Adebiyi AA, Aje A, Ogah OS, Ojji DB, Oladapo OO, Falase AO . Left ventricular diastolic function parameters in hypertensives. J Natl Med Assoc 2005; 97: 41–45.
de Simone G, Greco R, Mureddu G, Romano C, Guida R, Celentano A et al. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000; 101: 152–157.
Yamamoto K, Wilson DJ, Canzanello VJ, Redfield MM . Left ventricular diastolic dysfunction in patients with hypertension and preserved systolic function. Mayo Clin Proc 2000; 75: 148–155.
Onose Y, Oki T, Yamada H, Manabe K, Kageji Y, Matsuoka M et al. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging. Jpn Circ J 2001; 65: 305–309.
Wachtell K, Smith G, Gerdts E, Dahlof B, Nieminen MS, Papademetriou V et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study): Losartan Intervention For Endpoint. Am J Cardiol 2000; 85: 466–472.
Schussheim AE, Diamond JA, Jhang JS, Phillips RA . Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol 1998; 82: 1056–1059.
Bella JN, Palmieri V, Liu JE, Kitzman DW, Oberman A, Hunt SC et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension 2001; 38: 424–428.
Keser N, Yildiz S, Kurtog N, Dindar I . Modified TEI index: a promising parameter in essential hypertension? Echocardiography 2005; 22: 296–304.
Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357–366.
Tei C . New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26: 135–136.
Tei C, Nishimura RA, Seward JB, Tajik AJ . Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169–178.
Pellett AA, Tolar WG, Merwin DG, Kerut EK . The Tei index: methodology and disease state values. Echocardiography 2004; 21: 669–672.
Tekten T, Onbasili AO, Ceyhan C, Unal S, Discigil B . Novel approach to measure myocardial performance index: pulsed-wave tissue Doppler echocardiography. Echocardiography 2003; 20: 503–510.
Galiuto L, Ignone G, DeMaria AN . Contraction and relaxation velocities of the normal left ventricle using pulsed-wave tissue Doppler echocardiography. Am J Cardiol 1998; 81: 609–614.
Tekten T, Onbasili AO, Ceyhan C, Unal S, Discigil B . Value of measuring myocardial performance index by tissue Doppler echocardiography in normal and diseased heart. Jpn Heart J 2003; 44: 403–416.
Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K . Effect of cilnidipine, a novel dihydropyridine Ca2+-channel antagonist, on N-type Ca2+ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997; 280: 1184–1191.
Uneyama H, Uchida H, Konda T, Yoshimoto R, Akaike N . Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels. Eur J Pharmacol 1999; 373: 93–100.
Takami T, Shigematsu M . Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension. Clin Exp Hypertens 2003; 25: 525–535.
Tan HW, Li L, Ma ZY, Zhong XZ, Li JJ, Wang Y . TDI assessment of cilnidipine on left ventricular diastiolic function in hypertensive patients. Chine J Ultrasound 2005; 21: 427–429 (in Chinese).
Sahn DJ, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB . Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 658–664.
Choong CY, Herrmann HC, Weyman AE, Fifer MA . Preload dependence of Doppler-derived index of left ventricular diastolic funtion in humans. J Am Coll Cardiol 1987; 10: 800–808.
Kuo LC, Quinones MA, Rokey R, Sartori M, Abinader EG, Zoghbi WA . Quantification of atrial contribution to left ventricular filling by Pulsed Doppler echocardiography and the effect of age in normal and didiseased hearts. Am J Cardiol 1987; 59: 1174–1178.
Kang SM, Ha JW, Rim SJ, Chung N . Index of myocardial performance using Doppler-derived parameters in the evaluation of left ventricular function in patients with essential hypertension. Yonsei Med J 1998; 39: 446–452.
Palloshi A, Fragasso G, Silipigni C, Locatelli M, Cristell N, Pala MG et al. Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure. Am J Cardiol 2004; 94: 1456–1459.
Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005; 23: 183–191.
Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Pavarani C, Cavatorta A . Intracellular free [Ca2+] in circulating lymphocytes of spontaneously hypertensive rats. Life Sci 1984; 35: 535–542.
Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP . Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982; 46: 158–164.
Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90: 860–864.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, HW., Li, L., Zhang, W. et al. Effect of cilnidipine on left ventricular function in hypertensive patients as assessed by tissue Doppler Tei index. J Hum Hypertens 20, 618–624 (2006). https://doi.org/10.1038/sj.jhh.1002030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002030